Most Popular
-
1
Exports to US reach all-time high, widen gap with China
-
2
Trump rekindles criticism: US forces defending 'wealthy' S. Korea 'free of charge'
-
3
[Music in drama] Rekindle a love that slipped through your fingers
![[Music in drama] Rekindle a love that slipped through your fingers](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050484_0.jpg&u=20240501151646)
-
4
S. Korea discussed possible participation in AUKUS Pillar 2 with Australia: defense minister
-
5
[New faces of Assembly] Architect behind ‘audacious initiative’ believes in denuclearized North Korea
![[New faces of Assembly] Architect behind ‘audacious initiative’ believes in denuclearized North Korea](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050627_0.jpg&u=20240502093000)
![[Music in drama] Rekindle a love that slipped through your fingers](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050484_0.jpg&u=20240501151646)
![[New faces of Assembly] Architect behind ‘audacious initiative’ believes in denuclearized North Korea](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050627_0.jpg&u=20240502093000)
-
6
On May Day, labor unions blast Yoon's foreign nanny proposal
-
7
Seoul Metro to seek legal action against malicious complaints
-
8
[KH Explains] Will alternative trading platform shake up Korean stock market?
![[KH Explains] Will alternative trading platform shake up Korean stock market?](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050557_0.jpg&u=20240501161906)
-
9
Illit, mired in controversy, remains on Billboard charts for 5th week
-
10
S. Korea lowers COVID-19 warning level, lifts last-remaining antivirus mandates
![[KH Explains] Will alternative trading platform shake up Korean stock market?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/05/01/20240501050557_0.jpg&u=20240501161906)
Founded last year, Bridge Biotherapeutics is a local developer of biopharmaceuticals that focuses on commercializing compounds developed or discovered by a third party.
The company is currently working on BBT-401, anti-inflammatory agent discovered by a research team led by Sungkyunkwan University’s professor Park Seok-hee.
By Choi He-suk (cheesuk@heraldcorp.com)
-
Articles by Korea Herald
